Schroder Investment Management Group’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
Other funds holding EVH
EC
CCM
EAM
CCM
GIM
Schroder Investment Management Group's EVH Position: Q4 2024 in Review
Schroder Investment Management Group sold out of Evolent Health (EVH) in Q4 2024, closing a stake of 139,976 shares — an estimated $4.1M sold.
Schroder Investment Management Group first reported a position in EVH in Q2 2015 and held it in 18 quarters. The position peaked at $4.63M in Q4 2023. 240 funds tracked by Wall St. Rank hold EVH as of Q4 2024.
- Schroder Investment Management Group reported no remaining Evolent Health position as of Q4 2024 after selling out during the quarter.
- Schroder Investment Management Group sold 139,976 Evolent Health shares in Q4 2024, an estimated $4.1M.
- Schroder Investment Management Group first reported a position in Evolent Health in Q2 2015 and held it in 18 quarters.
- Schroder Investment Management Group's Evolent Health position peaked at $4.63M in Q4 2023.
- 240 funds tracked by Wall St. Rank held Evolent Health as of Q4 2024.
Based on Schroder Investment Management Group's 13F filing for Q4 2024, filed 12 Feb 2025.